Search details
1.
Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer.
Anticancer Drugs
; 34(10): 1183-1189, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-36727741
2.
Recombinant human endostatin combined with radiotherapy promotes cardiomyocyte apoptosis in rats via TGFß1/Smads/CTGF signaling pathway.
BMC Cardiovasc Disord
; 22(1): 97, 2022 03 12.
Article
in English
| MEDLINE | ID: mdl-35279096
3.
Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching.
Anticancer Drugs
; 30(3): 295-301, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30489288
4.
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies.
BMC Cancer
; 16(1): 908, 2016 11 21.
Article
in English
| MEDLINE | ID: mdl-27871270
5.
Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective study.
BMC Cancer
; 14: 491, 2014 Jul 08.
Article
in English
| MEDLINE | ID: mdl-25001175
6.
[Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 36(4): 268-72, 2014 Apr.
Article
in Zh
| MEDLINE | ID: mdl-24989912
7.
PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-ß1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis.
Inflammation
; 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38773023
8.
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.
BMC Cancer
; 13: 474, 2013 Oct 12.
Article
in English
| MEDLINE | ID: mdl-24118842
9.
Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy.
Front Oncol
; 13: 974735, 2023.
Article
in English
| MEDLINE | ID: mdl-37274290
10.
Impact of thoracic tumor radiotherapy on survival in non-small-cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study.
Cancer Med
; 12(14): 14949-14959, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37288833
11.
Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment.
Cancer Manag Res
; 14: 3347-3358, 2022.
Article
in English
| MEDLINE | ID: mdl-36465711
12.
Effect of PD-1 Inhibitor Combined with X-Ray Irradiation on the Inflammatory Microenvironment and Lung Tissue Injury in Mice.
J Inflamm Res
; 15: 545-556, 2022.
Article
in English
| MEDLINE | ID: mdl-35115804
13.
The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury.
J Inflamm Res
; 15: 6357-6371, 2022.
Article
in English
| MEDLINE | ID: mdl-36424918
14.
International consensus on radiotherapy in metastatic non-small cell lung cancer.
Transl Lung Cancer Res
; 11(9): 1763-1795, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36248338
15.
Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Chin J Cancer
; 30(8): 565-73, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21801605
16.
[The effect of overall treatment time on local control in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy].
Zhonghua Yi Xue Za Zhi
; 91(7): 469-72, 2011 Feb 22.
Article
in Zh
| MEDLINE | ID: mdl-21418978
17.
Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change.
Front Oncol
; 11: 705303, 2021.
Article
in English
| MEDLINE | ID: mdl-34631535
18.
Genetic characteristics of a patient with multiple primary cancers: A case report.
World J Clin Cases
; 9(28): 8563-8570, 2021 Oct 06.
Article
in English
| MEDLINE | ID: mdl-34754869
19.
Prognostic Model to Predict Overall Survival for Metastatic Non-Small Cell Lung Cancer Patients Treated With Chemotherapy Combined With Concurrent Radiation Therapy to the Primary Tumor: Analysis From Two Prospective Studies.
Front Oncol
; 11: 625688, 2021.
Article
in English
| MEDLINE | ID: mdl-33718191
20.
Simultaneous integrated boost of intensity-modulated radiation therapy to Stage II-III non-small cell lung cancer with metastatic lymph nodes.
Cancer Med
; 9(22): 8364-8372, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32902184